Works matching IS 13479032 AND DT 2022 AND VI 113 AND IP 3

Results: 26

Surgical volume threshold to improve 3‐year survival in designated cancer care hospitals in 2004‐2012 in Japan.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 1047, doi. 10.1111/cas.15264

By:

Okawa, Sumiyo;
Tabuchi, Takahiro;
Nakata, Kayo;
Morishima, Toshitaka;
Koyama, Shihoko;
Odani, Satomi;
Miyashiro, Isao

Publication type:

Article

Exosomes from M1‐polarized macrophages promote apoptosis in lung adenocarcinoma via the miR‐181a‐5p/ETS1/STK16 axis.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 986, doi. 10.1111/cas.15268

By:

Wang, Xuan;
Huang, Renhong;
Lu, Zhouyi;
Wang, Zheng;
Chen, Xiaofeng;
Huang, Dayu

Publication type:

Article

CXCR4 promotes the growth and metastasis of esophageal squamous cell carcinoma as a critical downstream mediator of HIF‐1α.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 926, doi. 10.1111/cas.15265

By:

Wu, Xianxian;
Zhang, Hongdian;
Sui, Zhilin;
Gao, Yongyin;
Gong, Lei;
Chen, Chuangui;
Ma, Zhao;
Tang, Peng;
Yu, Zhentao

Publication type:

Article

Utility of the Ba/F3 cell system for exploring on‐target mechanisms of resistance to targeted therapies for lung cancer.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 815, doi. 10.1111/cas.15263

By:

Koga, Takamasa;
Suda, Kenichi;
Mitsudomi, Tetsuya

Publication type:

Article

Treatment patterns and survival in advanced unresectable esophageal squamous cell cancer: A population‐based study.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 1038, doi. 10.1111/cas.15262

By:

Pape, Marieke;
Vissers, Pauline A.J.;
de Vos‐Geelen, Judith;
Hulshof, Maarten C.C.M.;
Gisbertz, Suzanne S.;
Jeene, Paul M.;
van Laarhoven, Hanneke W.M.;
Verhoeven, Rob H.A.

Publication type:

Article

Complement C1q binding protein regulates T cells' mitochondrial fitness to affect their survival, proliferation, and anti–tumor immune function.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 875, doi. 10.1111/cas.15261

By:

Tian, Hui;
Wang, Gang;
Wang, Qiping;
Zhang, Baofu;
Jiang, Guan;
Li, Huizhong;
Chai, Dafei;
Fang, Lin;
Wang, Meng;
Zheng, Junnian

Publication type:

Article

Cancer immunotherapy using artificial adjuvant vector cells to deliver NY‐ESO‐1 antigen to dendritic cells in situ.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 864, doi. 10.1111/cas.15259

By:

Fujii, Shin‐ichiro;
Yamasaki, Satoru;
Hanada, Kenichi;
Ueda, Shogo;
Kawamura, Masami;
Shimizu, Kanako

Publication type:

Article

ErbB4‐mediated regulation of vasculogenic mimicry capability in breast cancer cells.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 950, doi. 10.1111/cas.15258

By:

Kawahara, Ryota;
Simizu, Siro

Publication type:

Article

High prevalence of TERT aberrations in myxoid liposarcoma: TERT reactivation may play a crucial role in tumorigenesis.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 1078, doi. 10.1111/cas.15256

By:

Kunieda, Junko;
Yamashita, Kyoko;
Togashi, Yuki;
Baba, Satoko;
Sakata, Seiji;
Inamura, Kentaro;
Ae, Keisuke;
Matsumoto, Seiichi;
Machinami, Rikuo;
Kitagawa, Masanobu;
Takeuchi, Kengo

Publication type:

Article

Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC‐chip" for primary lung cancer.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 1028, doi. 10.1111/cas.15255

By:

Kanayama, Masatoshi;
Kuwata, Taiji;
Mori, Masataka;
Nemoto, Yukiko;
Nishizawa, Natsumasa;
Oyama, Rintaro;
Matsumiya, Hiroki;
Taira, Akihiro;
Shinohara, Shinji;
Takenaka, Masaru;
Yoneda, Kazue;
Kuroda, Koji;
Ohnaga, Takashi;
Tanaka, Fumihiro

Publication type:

Article

An aging‐related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 891, doi. 10.1111/cas.15254

By:

Zhang, Wenjing;
Li, Yuting;
Lyu, Juncheng;
Shi, Fuyan;
Kong, Yujia;
Sheng, Chao;
Wang, Suzhen;
Wang, Qinghua

Publication type:

Article

Identification of an IDO1‐based immune classifier for survival prediction of upper tract urothelial carcinoma.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 852, doi. 10.1111/cas.15253

By:

Zhong, Wenlong;
Yang, Meng;
Cheng, Sida;
Hou, Weibin;
Wang, Bo;
Chen, Junyu;
Yu, Hao;
Ouyang, Yi;
Wang, Xiaofei;
Ou, Ziwei;
Xu, Peiqi;
Li, Xuesong;
Zhou, Liqun;
Huang, Jian;
Wang, Chunhui;
Lin, Tianxin

Publication type:

Article

A modified MethyLight assay predicts the clinical outcomes of anti‐epidermal growth factor receptor treatment in metastatic colorectal cancer.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 1057, doi. 10.1111/cas.15252

By:

Ouchi, Kota;
Takahashi, Shin;
Okita, Akira;
Sakamoto, Yasuhiro;
Muto, Osamu;
Amagai, Kenji;
Okada, Takaho;
Ohori, Hisatsugu;
Shinozaki, Eiji;
Ishioka, Chikashi

Publication type:

Article

Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502‐A1.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 1018, doi. 10.1111/cas.15251

By:

Oshima, Kotoe;
Kato, Ken;
Ito, Yoshinori;
Daiko, Hiroyuki;
Nozaki, Isao;
Nakagawa, Satoru;
Shibuya, Yuichi;
Kojima, Takashi;
Toh, Yasushi;
Okada, Morihito;
Hironaka, Shuichi;
Akiyama, Yuji;
Komatsu, Yoshito;
Maejima, Kazuhiro;
Nakagawa, Hidewaki;
Onuki, Ritsuko;
Nagai, Momoko;
Kato, Mamoru;
Kanato, Keisuke;
Kuchiba, Aya

Publication type:

Article

Nanomedicine targets iron metabolism for cancer therapy.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 828, doi. 10.1111/cas.15250

By:

Lin, Liangru;
Chen, Hanqing;
Zhao, Ruifang;
Zhu, Motao;
Nie, Guangjun

Publication type:

Article

Next‐generation sequencing of endoscopically obtained tissues from patients with all stages of pancreatic cancer.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 1069, doi. 10.1111/cas.15249

By:

Takano, Shinichi;
Fukasawa, Mitsuharu;
Shindo, Hiroko;
Takahashi, Ei;
Fukasawa, Yoshimitsu;
Kawakami, Satoshi;
Hayakawa, Hiroshi;
Kuratomi, Natsuhiko;
Kadokura, Makoto;
Yamaguchi, Tatsuya;
Inoue, Taisuke;
Maekawa, Shinya;
Enomoto, Nobuyuki

Publication type:

Article

Squalene synthase predicts poor prognosis in stage I‐III colon adenocarcinoma and synergizes squalene epoxidase to promote tumor progression.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 971, doi. 10.1111/cas.15248

By:

Jiang, Huihong;
Tang, Erjiang;
Chen, Ying;
Liu, Hailong;
Zhao, Yun;
Lin, Moubin;
He, Luwei

Publication type:

Article

Enforced dual‐specificity tyrosine‐regulated kinase 2 expression by adenovirus‐mediated gene transfer inhibits tumor growth and metastasis of colorectal cancer.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 960, doi. 10.1111/cas.15247

By:

Imaizumi, Yuta;
Yoshida, Saishu;
Kanegae, Yumi;
Eto, Ken;
Yoshida, Kiyotsugu

Publication type:

Article

Development of an in vitro carcinogenesis model of human papillomavirus‐induced cervical adenocarcinoma.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 904, doi. 10.1111/cas.15246

By:

Zhang, Mengzhu;
Kiyono, Tohru;
Aoki, Kazunori;
Goshima, Naoki;
Kobayashi, Shin;
Hiranuma, Kengo;
Shiraishi, Kouya;
Saya, Hideyuki;
Nakahara, Tomomi

Publication type:

Article

MEK inhibition suppresses metastatic progression of KRAS‐mutated gastric cancer.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 916, doi. 10.1111/cas.15244

By:

Yamasaki, Juntaro;
Hirata, Yuki;
Otsuki, Yuji;
Suina, Kentaro;
Saito, Yoshiyuki;
Masuda, Kenta;
Okazaki, Shogo;
Ishimoto, Takatsugu;
Saya, Hideyuki;
Nagano, Osamu

Publication type:

Article

NLRP4 negatively regulates type I interferon response and influences the outcome in anti‐programmed cell death protein (PD)‐1/PD‐ligand 1 therapy.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 838, doi. 10.1111/cas.15243

By:

Wang, Hui;
Xia, Liliang;
Yao, Cheng‐cheng;
Dong, Hui;
Yang, Yi;
Li, Chong;
Ji, Wen‐xiang;
Sun, Rui‐ming;
Duan, Huang‐qi;
Mengzhou, Wenli;
Xia, Wei‐min;
Wang, Shu‐jun;
Ji, Ping;
Li, Ziming;
Jiao, Lei;
Wang, Ying;
Lu, Shun

Publication type:

Article

PolyI:C attenuates transforming growth factor‐β signaling to induce cytostasis of surrounding cells by secreted factors in triple‐negative breast cancer.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 940, doi. 10.1111/cas.15241

By:

Tamura, Yusuke;
Tsutsumi, Shuichi;
Miyazono, Kohei;
Koinuma, Daizo

Publication type:

Article

A phase 1 trial of xentuzumab, an IGF‐neutralizing antibody, in Japanese patients with advanced solid tumors.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 1010, doi. 10.1111/cas.15231

By:

Doi, Toshihiko;
Kuboki, Yasutoshi;
Naito, Yoichi;
Ishida, Masahiro;
Tanaka, Tetsuya;
Takeuchi, Yoshito

Publication type:

Article

Alpha‐actinin‐4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.

Published in:

Cancer Science, 2022, v. 113, n. 3, p. 1002, doi. 10.1111/cas.15228

By:

Noro, Rintaro;
Honda, Kazufumi;
Nagashima, Kengo;
Motoi, Noriko;
Kunugi, Shinobu;
Matsubayashi, Jun;
Takeuchi, Susumu;
Shiraishi, Hideaki;
Okano, Tetsuya;
Kashiro, Ayumi;
Meng, Xue;
Yoshida, Yukihiro;
Watanabe, Shunichi;
Usuda, Jitsuo;
Inoue, Tatsuya;
Wilber, Huang;
Ikeda, Norihiko;
Seike, Masahiro;
Gemma, Akihiko;
Kubota, Kaoru

Publication type:

Article

In this Issue.

Published in:: Cancer Science, 2022, v. 113, n. 3, p. 813, doi. 10.1111/cas.14948
Publication type:: Article

Issue Information.

Published in:: Cancer Science, 2022, v. 113, n. 3, p. 809, doi. 10.1111/cas.14947
Publication type:: Article